The Latest Cardiac and Vascular News
MARLBOROUGH, Mass., March 28, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the U.K. Court of Appeal dismissed Edwards Lifesciences‘ appeal and upheld a prior court decision that Edwards’ Sapien 3™ device infringes Boston Scientific patent EP (UK) 2 926 766 […]
MARLBOROUGH, Mass., March 26, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2018 on Wednesday, April 25, 2018 at 8:00 a.m. EDT. The call will be hosted by Mike Mahoney, chairman […]
WASHINGTON, March 23, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the United States Patent and Trademark Office (USPTO) decided in Edwards’ favor in an Inter Partes […]
BARCELONA, Spain and MARLBOROUGH, Mass., March 20, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain. The data […]
MARLBOROUGH, Mass., March 14, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 17th Annual Needham Healthcare Conference on Tuesday, March 27, 2018 in New York City. Susie Lisa, vice president, Investor Relations, and Lindsay Fish, senior manager, Investor Relations, will participate in […]
MARLBOROUGH, Mass., March 12, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced key data presentations that will be featured at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain, on March 18-20. Notably, there will be three late-breaking clinical trials […]
Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All […]
This first of it’s kind trial compares two leading DCB technologies. Boston Scientific’s drug-coated balloon goes up against Medtronic’s DCB in first-of-its-kind trial JANUARY 31, 2018 BY SARAH FAULKNER, Drug Delivery Business NEws Top-line results from a head-to-head trial comparing Boston Scientific‘s (NYSE:BSX) […]
MARLBOROUGH, Mass., Jan. 24, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment […]
MARLBOROUGH, Mass., Jan. 9, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales, based upon preliminary unaudited financial information, of approximately $2.41 billion during the fourth quarter ended December 31, 2017. This represents growth of approximately 9.9 percent on a reported […]
